7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

Playing in the field of nano-cap stocks is similar to the concept of stealing bases. In a tight baseball game, every advantage counts. Therefore, you might get the signal from the manager to steal a bag. You could end up being the hero or end up looking like a fool.

It’s a binary proposition: high risk, high reward. And while advantages help break up a tight game, you also don’t want to give up cheap outs. That could put you in a serious disadvantage. And that’s why people seldom invest heavily in nano-cap stocks or companies that feature a market capitalization of $50 million or less. It’s just too risky.

Nevertheless, in certain situations – maybe the runner is fast and the opposing catcher is slow to react – an attempt to steal might make sense. With nano-cap stocks, you might want to consider only compelling enterprises with analyst backing.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Yeah, even in this speculative subsegment, Wall Street experts might give a tip of the hat. If you want to gamble, here are the nano-cap stocks to consider.

Passage Bio (PASG)

Page of newspaper with words penny stocks. high return penny stocks
Page of newspaper with words penny stocks. high return penny stocks

Source: Vitalii Vodolazskyi / Shutterstock.com

What it is: A biotechnology company, Passage Bio (NASDAQ:PASG) focuses on therapeutics for neurodegenerative diseases. Currently, the company carries a market cap of $54.18 million, which admittedly is a bit above the threshold for nano-cap stocks.

Relevance: Still, if you’ll grant me a mulligan – and there will be another one coming up – Passage Bio deserves to be on your radar. Fundamentally, it plies its trade in an ultra-relevant sector. By year’s end, the neurodegenerative disease therapeutics market size will reach a valuation of $51.45 billion. Further, the sector may expand at a compound annual growth rate (CAGR) of 7.14%, leading to a value of $72.63 billion.

Pros: Analysts rate shares a moderate buy with a $7 price target. That implies almost 610% upside potential. Also, it’s been on the run, gaining 59% in the trailing one-month period.

Cons: Since its public market debut in 2020, PASG lost almost 96% of equity value. Thus, you want to be extremely careful here.

AudioEye (AEYE)

Image of a penny held between two fingers with a white indoor background
Image of a penny held between two fingers with a white indoor background

Source: Shutterstock

What it is: Leveraging artificial intelligence, AudioEye (NASDAQ:AEYE) primarily serves in the digital accessibility platform industry. Presently, the company carries a market cap of $50.29 million. Again, that’s just a bit over the threshold for nano-cap stocks.

Relevance: If you’ll overlook the technicality for a second time, AudioEye entices speculators because of its underlying relevance. We all know how much AI and machine learning has blossomed in 2023. However, the digital accessibility software market is starting to grow. Right now, the sector features a valuation of $706.15 million. However, over the next five years, the sector could reach $958.7 million.